Nonin Medical’s Christopher Holland Promoted to Chief Commercial Officer
MINNEAPOLIS, September 28, 2015 (PR NEWSWIRE)–Nonin Medical, Inc., a global leader in noninvasive medical monitoring, today announced that Christopher Holland has been promoted from Vice President of Business Development to Chief Commercial Officer (CCO). As CCO, Mr. Holland will continue to lead business development, in addition to overseeing the company’s commercialization strategies and activities.
"Chris Holland has been instrumental to Nonin Medical’s growth, particularly in regional oximetry and global partnerships,” said Nonin Medical Chief Executive Officer Philip Isaacson. “Because the healthcare industry has become more complex, Chris will align the company around fully understanding, representing and managing the customer experience. This critical role will help Nonin better serve our customers and fulfill our vision of improving the quality of people’s lives.”
Mr. Holland holds two patents and has held multiple leadership positions at Nonin Medical since 2008. Most recently, he served as Vice President of Business Development and as Director of Marketing for the company’s regional oximetry business. He previously held senior management and consulting positions at Cisco Systems and PricewaterhouseCoopers. Mr. Holland has a Bachelor of Science degree in computer science and math from Minnesota State University.
Nonin Medical, Inc. invented the finger pulse oximeter (the original Onyx® brand) and designs and manufactures noninvasive medical monitoring solutions that meet customers’ technology needs today and tomorrow. Headquartered in Plymouth, Minn., USA, with an additional customer service center in Amsterdam, the Netherlands, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company has more than 300 OEM partners worldwide. For more information, visit nonin.com.